Updated Oct 9, 2026 · 04:30 UTC
PFEPfizer Inc
Health Care · United States · XNYS · pharmaceutical preparations
$27.79−0.64%last session · market closed
Market cap
$158.40b
real-world
Tokenized
$3.9m
0.002% of the asset
Avg token price
$28.09
+1.06% vs real
Spot volume, 24h
$5k
3 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
PFE · Price
Sep 4, 2025low $24.00 · high $30.55 · now $29.04Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Nov 3
before the open · Sep 2026 quarter · EPS forecast $0.75 (5 analysts)
Last earnings, Aug 4
$0.77 EPS
+13.2% vs $0.68 forecast · Jun 2026 quarter
Real market
Pfizer Inc.
Last close
$28.00
Oct 7
Traded on Oct 7
$874.2m
Price now
$27.79
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $5k · 3 venues
Kraken1 pair$3k
Ondo Stocks1 pair$2k
Deluthium1 pair—Derivatives · — · 0 venues
None yet
Onchain versions
5 tokens from 4 issuers
PFEonOndo Assets$29.51$3.5m
PFEXBacked Assets$27.15$341k
PFE.DDinari Assets——
WPFEXBacked Assets——
PFEcCoinbase——By chain
Where the tokens circulate, issuers’ unsold stock taken off
Ethereum90%$3.5m
Solana8.8%$341k
BNB Chain1.2%$47k
Ink0.2%$8kIn DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$63.70b
−0% YoY
Net income
$4.33b
7% margin · −60% YoY
EPS, diluted
$0.76
−60% YoY
Cash and balance sheet
Free cash flow
$10.98b
17% of revenue
Net debt
$54.94b
$8.26b cash and securities, $63.19b debt
Diluted shares
5.70b
−0% YoY
Valuation at today’s market cap
P/E
37×
EV / sales
3.3×
enterprise value $213.34b
Free cash flow yield
6.9%
Quarterly
RevenueNet income